Hideto Ito

530 total citations
34 papers, 401 citations indexed

About

Hideto Ito is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hideto Ito has authored 34 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 15 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Hideto Ito's work include Gastric Cancer Management and Outcomes (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Metastasis and carcinoma case studies (6 papers). Hideto Ito is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Metastasis and carcinoma case studies (6 papers). Hideto Ito collaborates with scholars based in Japan. Hideto Ito's co-authors include Kazuhito Mita, Takashi Hayashi, Kazuya Koizumi, Hideki Asakawa, Kohzoh Imai, Yasushi Adachi, David P. Carbone, Fumio Itoh, Hiroyuki Yamamoto and Hiroyuki Kikuchi and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, The American Journal of Surgery and Annals of Surgical Oncology.

In The Last Decade

Hideto Ito

32 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideto Ito Japan 12 170 154 145 114 55 34 401
Mehmet Küçüköner Türkiye 14 115 0.7× 253 1.6× 230 1.6× 116 1.0× 80 1.5× 74 591
Anders Christian Larsen Denmark 12 122 0.7× 100 0.6× 176 1.2× 127 1.1× 114 2.1× 28 405
P. Sandbichler Austria 11 291 1.7× 190 1.2× 94 0.6× 64 0.6× 17 0.3× 26 456
Ayşe Ocak Duran Türkiye 11 96 0.6× 119 0.8× 197 1.4× 82 0.7× 65 1.2× 44 439
Giacomo Benassai Italy 12 336 2.0× 126 0.8× 362 2.5× 28 0.2× 92 1.7× 44 545
Ichiro Kasahara Japan 12 128 0.8× 122 0.8× 63 0.4× 71 0.6× 25 0.5× 19 362
George Papastratis Greece 14 304 1.8× 129 0.8× 213 1.5× 70 0.6× 50 0.9× 30 461
Ji Hyun Lee South Korea 11 117 0.7× 162 1.1× 331 2.3× 83 0.7× 99 1.8× 49 544
Angelika Bezan Austria 11 136 0.8× 159 1.0× 177 1.2× 66 0.6× 89 1.6× 16 389
Daisuke Yasui Japan 10 118 0.7× 116 0.8× 71 0.5× 32 0.3× 28 0.5× 48 289

Countries citing papers authored by Hideto Ito

Since Specialization
Citations

This map shows the geographic impact of Hideto Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideto Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideto Ito more than expected).

Fields of papers citing papers by Hideto Ito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideto Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideto Ito. The network helps show where Hideto Ito may publish in the future.

Co-authorship network of co-authors of Hideto Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Hideto Ito. A scholar is included among the top collaborators of Hideto Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideto Ito. Hideto Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ito, Hideto, et al.. (2017). Does antithrombotic therapy improve survival with colorectal cancer?. World Journal of Surgical Oncology. 15(1). 161–161. 2 indexed citations
2.
Ito, Hideto, et al.. (2017). Association between antithrombotic therapy and risk of postoperative complications among patients undergoing endovenous laser ablation. Journal of Vascular Surgery Venous and Lymphatic Disorders. 5(3). 339–345. 4 indexed citations
3.
Mita, Kazuhito, et al.. (2017). Adjuvant Chemotherapy with S-1 plus Cisplatin for Patients with Stage III Gastric Cancer After Curative Resection. Anticancer Research. 37(3). 1329–1334. 2 indexed citations
4.
Mita, Kazuhito, et al.. (2017). Prognostic Factors Affecting Survival After Multivisceral Resection in Patients with Clinical T4b Gastric Cancer. Journal of Gastrointestinal Surgery. 21(12). 1993–1999. 18 indexed citations
5.
Ito, Hideto, Ayaka Tsuboi, Masatoshi Hashimoto, et al.. (2016). Associations between antithrombotic therapy and the risk of perioperative complications among patients undergoing laparoscopic gastrectomy. Surgical Endoscopy. 31(2). 567–572. 3 indexed citations
6.
Ito, Hideto, Ayaka Tsuboi, Masatoshi Hashimoto, et al.. (2016). Treatment of Chilaiditi syndrome using laparoscopic surgery. Asian Journal of Endoscopic Surgery. 10(1). 63–65. 7 indexed citations
7.
Ito, Hideto, Ayaka Tsuboi, Masatoshi Hashimoto, et al.. (2015). Immunoglobulin G4-related sclerosing cholecystitis presenting as gallbladder cancer: a case report. Surgical Case Reports. 1(1). 120–120. 11 indexed citations
8.
Mita, Kazuhito, Hideto Ito, Masatoshi Hashimoto, et al.. (2015). Postpancreatectomy Hemorrhage After Pancreatic Surgery in Patients Receiving Anticoagulation or Antiplatelet Agents. Surgical Innovation. 23(3). 284–290. 15 indexed citations
9.
Mita, Kazuhito, Hideto Ito, Masatoshi Hashimoto, et al.. (2013). Postoperative Complications and Survival after Gastric Cancer Surgery in Patients Older than 80 Years of Age. Journal of Gastrointestinal Surgery. 17(12). 2067–2073. 25 indexed citations
10.
11.
Mita, Kazuhito, et al.. (2012). Postoperative Bleeding Complications after Gastric Cancer Surgery in Patients Receiving Anticoagulation and/or Antiplatelet Agents. Annals of Surgical Oncology. 19(12). 3745–3752. 44 indexed citations
12.
Mita, Kazuhito, et al.. (2011). Alternating Treatment with S-1 Plus Low-Dose Cisplatin and S-1 Alone for Advanced Gastric Cancer. Journal of Gastrointestinal Surgery. 15(5). 791–796. 2 indexed citations
13.
Mita, Kazuhito, et al.. (2011). Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer. The American Journal of Surgery. 203(1). 107–111. 27 indexed citations
14.
Mita, Kazuhito, et al.. (2010). Gemcitabine and S-1 Combination Chemotherapy in Patients with Advanced Biliary Tract Cancer:A Retrospective Study. Case Reports in Oncology. 3(3). 498–504. 2 indexed citations
15.
16.
Abe, Tamaki, Minoru Toyota, Hiromu Suzuki, et al.. (2005). Upregulation of BNIP3 by 5-aza-2′-deoxycytidine sensitizes pancreatic cancer cells to hypoxia-mediated cell death. Journal of Gastroenterology. 40(5). 504–510. 52 indexed citations
17.
Ito, Hideto, et al.. (2003). A 25-year clinical history of portopulmonary hypertension associated with latent myeloproliferative disorder. Journal of Gastroenterology. 38(5). 488–492. 10 indexed citations
18.
Min, Yongfen, Yasushi Adachi, Hiroyuki Yamamoto, et al.. (2003). Genetic blockade of the insulin-like growth factor-I receptor: a promising strategy for human pancreatic cancer.. PubMed. 63(19). 6432–41. 76 indexed citations
19.
Yasui, Wataru, Kenichi Yoshida, Hideto Ito, & E Tahara. (1991). Molecular diagnosis on gastric cancer. Gan to kagaku ryōhō. 18(1). 7–13.
20.
Miyazaki, Masaru, et al.. (1990). [Transcatheter embolization of splenic artery aneurysm; a case report].. PubMed. 35(5). 641–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026